Systematic Review and Pooled Analysis of the Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial Nephrectomy [0.03%]
系统评价和汇总分析肾部分切除术后不同缝合技术对肾脏功能影响的研究
Riccardo Bertolo,Riccardo Campi,Maria Carmen Mir et al.
Riccardo Bertolo et al.
Despite the important relationship between renorrhaphy and functional outcomes of partial nephrectomy, the urological guidelines do not provide recommendations about the optimal renorrhaphy technique. We carried out the first pooled literat...
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy [0.03%]
不适合接受以顺铂为基础的疗法的晚期、不能手术或转移性尿路上皮癌患者使用派姆单抗的疗效成本分析研究结果
Karl Patterson,Vimalanand Prabhu,Ruifeng Xu et al.
Karl Patterson et al.
Background: There is an unmet need for effective therapies for patients with advanced or metastatic urothelial cancer who cannot tolerate cisplatin-based chemotherapy. Cisplatin-ineligible patients experience a high frequ...
Comparative Study
European urology oncology. 2019 Sep;2(5):565-571. DOI:10.1016/j.euo.2018.09.009 2019
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer [0.03%]
通过外周血循环肿瘤细胞的全外显子组测序分析转移性前列腺癌中的突变特征
Vincent Faugeroux,Céline Lefebvre,Emma Pailler et al.
Vincent Faugeroux et al.
Background: Genomic analysis of circulating tumor cells (CTCs) could provide a unique and accessible representation of tumor diversity but remains hindered by technical challenges associated with CTC rarity and heterogene...
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review [0.03%]
前列腺癌表观扩散系数与Gleason评分相关性系统评价
Alexey Surov,Hans Jonas Meyer,Andreas Wienke
Alexey Surov
Background: Reported data regarding the associations between apparent diffusion coefficient (ADC) of diffusion-weighted imaging (DWI) and Gleason score in prostate cancer (PC) are inconsistent. ...
Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies [0.03%]
成人肾肉瘤全面基因组分析揭示疾病生物学特征及靶向治疗机会
Evgeny Yakirevich,Russell Madison,Eduard Fridman et al.
Evgeny Yakirevich et al.
Background: Primary adult renal sarcomas (RSs) are rare aggressive neoplasms. Clinical outcomes are extremely poor, and optimal treatment remains challenging. ...
Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer [0.03%]
睾丸癌术后机器人后腹膜淋巴结清扫术
Roger Li,Jonathan J Duplisea,Firas G Petros et al.
Roger Li et al.
Background: Postchemotherapy retroperitoneal lymph node dissection (pcRPLND) is mandated in patients with nonseminomatous germ cell tumor found to have residual masses after chemotherapy. Performed via the open approach, ...
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy [0.03%]
低前列腺特异性膜抗原（PSMA）表达的转移性去势抵抗性前列腺癌患者不适合使用177Lu标记的PSMA放射配体治疗的不良结局
Sue Ping Thang,John Violet,Shahneen Sandhu et al.
Sue Ping Thang et al.
Background: Prostate-specific membrane antigen (PSMA) is overexpressed in metastatic castration-resistant prostate cancer (mCRPC) and represents a target for imaging and therapy. We undertook a prospective trial of 177Lu-...
Clinical Trial
European urology oncology. 2019 Nov;2(6):670-676. DOI:10.1016/j.euo.2018.11.007 2019
Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy [0.03%]
评估根治性前列腺切除术前勃起功能的两种方法比较
Carlo Andrea Bravi,Amy Tin,Nicole Benfante et al.
Carlo Andrea Bravi et al.
Patient-reported outcome instruments for erectile function often ask respondents about their experience over the previous 4wk. This is problematic for baseline assessment of patients with prostate cancer (PC) before treatment, as the previo...
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study [0.03%]
循环肿瘤DNA改变与晚期尿路上皮癌临床结局的关系：一项试点研究
Petros Grivas,Aly-Khan A Lalani,Gregory R Pond et al.
Petros Grivas et al.
Cell-free circulating DNA (cfDNA) can be used for noninvasive profiling of tumor genomic aberrations. We hypothesized that molecular alterations may inform prognostication in advanced urothelial carcinoma (aUC). We evaluated 124 aUC patient...
Multicenter Study
European urology oncology. 2020 Oct;3(5):695-699. DOI:10.1016/j.euo.2019.02.004 2020
Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors [0.03%]
CT纹理分析在预测转移性尿路上皮癌程序性死亡-1和程序性死亡配体-1抑制剂疗效中的作用
Francesco Alessandrino,Rahul Gujrathi,Amin H Nassar et al.
Francesco Alessandrino et al.
Background: Reliable biomarkers to predict the response of metastatic urothelial cancer (mUC) to programmed death-1 and programmed death-ligand 1 (PD-1/PD-L1) inhibitors are being investigated. Texture analysis represents...